Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F]Fluorodeoxyglucose PET-MRIYasuko Morita, Wataru Ogawa, Munenobu Nogami et al.|Diabetes Care|2020Cited by 60
Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitorAnna So, Wataru Ogawa, Yuko Okada et al.|Endocrine Journal|2020Cited by 50
Dose‐dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by <sup>18</sup> F‐labelled fluorodeoxyglucose positron emission tomography‐ <scp>MRI</scp>Jun Ito, Wataru Ogawa, Munenobu Nogami et al.|Diabetes Obesity and Metabolism|2020Cited by 23
Metformin action in the gut―insight provided by [18F]FDG PET imagingHitomi Tsuchida, Wataru Ogawa, Yasuko Morita et al.|Diabetology International|2021Cited by 16
Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic‐euglycemic clamp analysis in individuals with type 2 diabetesNatsu Otowa‐Suematsu, Wataru Ogawa, Kazuhiko Sakaguchi et al.|Journal of Diabetes Investigation|2021Cited by 14